It seems to be because analysts and larger biotech investors w huge followers still associate this w Shkreli and call it a pinksheet scam. It’s unfortunate that they still have that stigma attached to them.
Agree maybe that’s why all the writers keep leading with old Marty . If this doesn’t run through he high it will be because of what you described. When is this horse going to get a little respect?